{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:31:38Z","timestamp":1783031498218,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.vaccine.2008.08.065","type":"journal-article","created":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T08:57:07Z","timestamp":1221814627000},"page":"5822-5829","source":"Crossref","is-referenced-by-count":39,"title":["Cysteine proteinase type III is protective against Leishmania infantum infection in BALB\/c mice and highly antigenic in visceral leishmaniasis individuals"],"prefix":"10.1016","volume":"26","author":[{"given":"Naghmeh","family":"Khoshgoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Zahedifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiva","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Taslimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel Jim\u00e9nez","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Rafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.08.065_bib1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.065_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"Dye","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.08.065_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/000349803225002499","article-title":"Leishmania\/HIV co-infections: epidemiology in Europe","volume":"97","author":"Desjeux","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.065_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus coinfection: the first 10 years","volume":"10","author":"Alvar","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.065_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between Leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"10.1016\/j.vaccine.2008.08.065_bib6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop Med Int Health"},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.065_bib7","first-page":"411","article-title":"Drug resistance mechanisms in clinical isolates of Leishmania donovani","volume":"123","author":"Singh","year":"2006","journal-title":"Indian J Med Res"},{"issue":"4","key":"10.1016\/j.vaccine.2008.08.065_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1368-7646(98)80007-1","article-title":"Drug resistance in Leishmania: similarities and differences to other organisms","volume":"1","author":"Papadopoulou","year":"1998","journal-title":"Drug Resist Updat"},{"issue":"3\/4","key":"10.1016\/j.vaccine.2008.08.065_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.vetpar.2006.08.019","article-title":"Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate","volume":"143","author":"Ikeda-Garcia","year":"2007","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.08.065_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00034989860003","article-title":"Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis","volume":"92","author":"Oliva","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.vaccine.2008.08.065_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.icb7100011","article-title":"Balancing immunity and pathology in visceral leishmaniasis","volume":"85","author":"Stanley","year":"2007","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.065_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.42.2.702-707.1983","article-title":"Cell mediated immune response in Indian kala-azar and post kala-azar dermal leishmaniasis","volume":"42","author":"Haldar","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.08.065_bib13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/infdis\/165.3.535","article-title":"Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi","volume":"165","author":"Carvalho","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.08.065_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.micpath.2004.11.002","article-title":"Immunopathogenesis of infection with the visceralizing Leishmania species","volume":"38","author":"Wilson","year":"2005","journal-title":"Microb Pathogen"},{"key":"10.1016\/j.vaccine.2008.08.065_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(06)64001-3","article-title":"Leishmania and the Leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans","volume":"64","author":"Banuls","year":"2007","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.vaccine.2008.08.065_bib16","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/IAI.61.3.1069-1073.1993","article-title":"Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis","volume":"61","author":"Kemp","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.08.065_bib17","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"Kedzierski","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2008.08.065_bib18","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum","volume":"23","author":"Rafati","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.065_bib19","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.vaccine.2005.11.011","article-title":"Prime-boost vaccination using cysteine proteinases types I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis","volume":"24","author":"Rafati","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.065_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0020-7519(00)00037-0","article-title":"Identification of 30kDa antigens from Leishmania (L.) chagasi amastigotesimplicated in protective cellular responses in amurine model","volume":"30","author":"Pinto","year":"2000","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2008.08.065_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.vaccine.2007.11.044","article-title":"Immunixation with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis","volume":"26","author":"Ferreia","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.065_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(01)00438-8","article-title":"Cysteine proteases of parasitic organisms","volume":"120","author":"Sajid","year":"2002","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2008.08.065_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1389202033490439","article-title":"Leishmania cysteine proteinases: from gene to subunit vaccine","volume":"4","author":"Rafati","year":"2003","journal-title":"Curr Genom"},{"key":"10.1016\/j.vaccine.2008.08.065_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-6851(97)00072-8","article-title":"cathepsin B-like cysteine proteinase-deficient mutants of Leishmania mexicana","volume":"88","author":"Bart","year":"1997","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.vaccine.2008.08.065_bib25","doi-asserted-by":"crossref","first-page":"25305","DOI":"10.1074\/jbc.M203034200","article-title":"Functional analysis of Cathepsin B-like cysteine proteases from Leishmania donovani complex","volume":"28","author":"Somanna","year":"2002","journal-title":"Biol Chem"},{"issue":"25-26","key":"10.1016\/j.vaccine.2008.08.065_bib26","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/S0264-410X(01)00081-0","article-title":"A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major","volume":"19","author":"Rafati","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.065_bib27","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.vaccine.2003.11.014","article-title":"Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis","volume":"22","author":"Zadeh-Vakili","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.065_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2005.01.009","article-title":"T helper(h)1\/Th2 and Leishmania: paradox rather than paradigm","volume":"99","author":"Alexander","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2008.08.065_bib29","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","volume":"174","author":"Basu","year":"2005","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.065_bib30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.42.2.702-707.1983","article-title":"Cell-mediated immune response in Indian kala azar and post-kala azar dermal leishmaniasis","volume":"42","author":"Haldar","year":"1983","journal-title":"Infection and Immunity"},{"issue":"4","key":"10.1016\/j.vaccine.2008.08.065_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.micpath.2004.11.002","article-title":"Immunopathogenesis of infection with the visceralizing Leishmania species","volume":"38","author":"Wilson","year":"2005","journal-title":"Microb Pathog"},{"issue":"8","key":"10.1016\/j.vaccine.2008.08.065_bib32","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:40:38Z","timestamp":1684543238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08011353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":32,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0264410X08011353"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}